Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · IEX Real-Time Price · USD
0.398
-0.042 (-9.50%)
Jul 22, 2024, 11:07 AM EDT - Market open
Aptevo Therapeutics Employees
Aptevo Therapeutics had 40 employees as of December 31, 2023. The number of employees decreased by 5 or -11.11% compared to the previous year.
Employees
40
Change (1Y)
-5
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$675,475
Market Cap
3.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Fresh2 Group | 75 |
Aditxt | 47 |
Scinai Immunotherapeutics | 31 |
Enveric Biosciences | 7 |
Portage Biotech | 7 |
Ensysce Biosciences | 7 |
ZyVersa Therapeutics | 7 |
Protagenic Therapeutics | 3 |
APVO News
- 20 days ago - Aptevo Therapeutics Announces Closing of $2.75 Million Offering - Accesswire
- 24 days ago - Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules - Accesswire
- 7 weeks ago - Aptevo Participating in the BIO International Convention - Accesswire
- 2 months ago - Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA - Accesswire
- 2 months ago - Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update - Accesswire
- 3 months ago - Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering - Accesswire
- 3 months ago - Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering - Accesswire
- 3 months ago - Aptevo Therapeutics Provides Pipeline Update - Accesswire